Ajou University School of Medicine
ajou.ac.krLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
173
Active
7
Phase 3
3
Total enrollment
10,296,151
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Sugammadex | — | — | — | — | — | 3 | |
| Monotherapy | — | — | — | — | — | 1 | |
| Combination therapy | — | — | — | — | — | 1 | |
| Maxigesic administration | — | — | — | — | — | 1 |
Next readouts
- 2025-07-28
- 2025-10-03
- 2026-08-31
Top conditions
- Gastric Cancer8
- Intubation;Difficult7
- Drug Usage6
- Gallbladder Diseases6
- Intubation6
- Obesity5
- Trauma5
- Ischemic Stroke4
Frequently asked questions about Ajou University School of Medicine
- How many clinical trials does Ajou University School of Medicine have on ClinicalTrials.gov?
- Ajou University School of Medicine is listed as the lead sponsor on 173 clinical trials in ClinicalTrials.gov, 7 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Ajou University School of Medicine's trials are in Phase 3?
- 3 of Ajou University School of Medicine's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Ajou University School of Medicine focus on?
- Ajou University School of Medicine's most-studied conditions on ClinicalTrials.gov are Gastric Cancer, Intubation;Difficult, Drug Usage, Gallbladder Diseases, Intubation.
- When are Ajou University School of Medicine's next clinical trial readouts?
- Ajou University School of Medicine has 3 upcoming primary-completion readouts tracked here; the soonest is “Immediate Fracture Risk After Antihypertensive Drug Initiation”, expected around 2025-07-28.